$BMY Recent News Earnings roundup: Cubist, Merck gain

New Post Public Reply Private Reply Replies (0) Message Board

May 2, 2014 at 9:38 AM

$BMY Recent News

Earnings roundup: Cubist, Merck gain as HCA, Bristol-Myers slide 11:48 a.m. April 29, 2014 - Russ Britt
Value trumps growth as investors pick Exxon over Tesla 10:48 a.m. April 29, 2014 - William L. Watts
Twitter, eBay, Sprint, Herbalife are stocks to watch 5:31 a.m. April 29, 2014 - Sue Chang
Market leaders energy, utilities face earnings gauntlet 11:17 a.m. April 28, 2014 - Wallace Witkowski
The market in a minute: Sell calls and puts 11:11 a.m. April 28, 2014 - The Trading Deck
GlaxoSmithKline exits cancer drugs 8:36 a.m. April 22, 2014 - MarketWatch.com
Merck: Hepatitis C drug has 98% cure rate in trial 11:43 a.m. April 10, 2014 - MarketWatch.com
Market rookie Five Prime's shares surge on deal with Bristol-Myers 12:01 p.m. March 17, 2014 - Russ Britt
RadioShack sinks; J.C. Penney gains on S&P outlook hike 5:19 p.m. March 4, 2014 - Sue Chang
Bristol-Myers plans late-stage tests on Yervoy as lung-cancer treatment 5:01 p.m. March 4, 2014 - Russ Britt
Billionaire Stan Druckenmiller's recent moves 12:50 p.m. Feb. 24, 2014 - Insider Monkey
Feds, pharma rivals team up on Alzheimer's 3:32 p.m. Feb. 6, 2014 - Elizabeth O'Brien
Merck hits a new high as analyst sees opening for new cancer drug 12:16 p.m. Jan. 27, 2014 - Russ Britt
U.S. stocks tumble; Dow drops 318 points 6:29 p.m. Jan. 24, 2014 - Anora Mahmudova
Juniper buoyed by Jana stake; Herbalife loss grows 4:50 p.m. Jan. 24, 2014 - Sue Chang
U.S. stock futures trim losses ahead of market open 9:57 a.m. Jan. 24, 2014 - Barbara Kollmeyer
Beam, Honeywell, Procter & Gamble are stocks to watch 6:38 a.m. Jan. 24, 2014 - Sue Chang
AstraZeneca, Bristol-Myers Secure EU OK for Xigduo 3:44 a.m. Jan. 22, 2014 - MarketWatch.com
‘Sloppy’ market turns to consumer, tech earnings 9:01 a.m. Jan. 19, 2014 - Wallace Witkowski
America's best and most generous 401(k)s 3:30 p.m. Jan. 15, 2014 - Anne Tergesen

Health Care Stocks Still Healthy Despite Higher Hedging Costs 6:30 a.m. Today - TheStreet.com
Bristol-Myers Squibb Company (BMY): Today's Featured Drugs Laggard 5:01 p.m. May 1, 2014 - TheStreet.com
Bristol-Myers Squibb's (BMY) CEO John Elicker on Q1 2014 Earnings - Call Transcript 12:26 p.m. April 30, 2014 - TheStreet.com
New Melanoma Therapies Are Ready For Primetime: Sanjiv Agarwala 10:37 a.m. April 30, 2014 - Seeking Alpha
6 Drugs That Could Move the Pharma Market 9:24 a.m. April 30, 2014 - Wall St. Cheat Sheet
Celgene Deal Chief Calls Big Pharma Gutless For Lack of Biotech M&A 4:26 p.m. April 29, 2014 - TheStreet.com
Bristol-Myers Squibb's CEO Discusses Q1 2014 Results - Earnings Call Transcript 3:04 p.m. April 29, 2014 - Seeking Alpha
Bristol-Myers Reports Higher Earnings, Biotech Buy 2:07 p.m. April 29, 2014 - The Wall Street Journal Interactive Edition
Why Bristol-Myers Squibb (BMY) Stock Is Down Today 12:44 p.m. April 29, 2014 - TheStreet.com
Bristol, Merck, Sanofi Report Soft Q1 Sales 11:15 a.m. April 29, 2014 - Investors Business Daily
6 Drugs That Could Move the Market 9:58 a.m. April 29, 2014 - Wall St. Cheat Sheet
10-Q: BRISTOL MYERS SQUIBB CO 9:51 a.m. April 29, 2014 - Edgar Online - (EDG = 10Q, 10K)
Bristol-Myers Squibb Company (BMY) Is Today's Pre-Market Laggard Stock 9:39 a.m. April 29, 2014 - TheStreet.com
Top 5 Responsible Corporations in the U.S. 9:22 a.m. April 29, 2014 - Wall St. Cheat Sheet
Bristol-Myers Squibb Company Discusses Q1 2014 Results (Webcast) 8:55 a.m. April 29, 2014 - Seeking Alpha
More on Bristol-Myers Q1: Buys iPierian for $175M up front 8:44 a.m. April 29, 2014 - Seeking Alpha
UPDATE: Bristol-Myers Posts Higher Q1 Profit 7:44 a.m. April 29, 2014 - benzinga.com
Bristol-Myers Squibb Acquires iPierian for $175M, Potential Milestone Payments of $550M 6:08 a.m. April 29, 2014 - benzinga.com
'Fast Money' Recap: The Problem With Growth Stocks 5:00 a.m. April 29, 2014 - TheStreet.com
AstraZeneca Chief Puts Cancer Drugs Ahead of Deals 9:12 p.m. April 28, 2014 - The Wall Street Journal Interactive Edition

Approvals from the European Commission and Release of Quarterly Financial Results - Analyst Notes on Merck, Johnson & Johnson, Bristol-Myers Squibb, Teva and AbbVie 8:00 a.m. Today - PR Newswire - PRF
Technical Recap on Pharma Equities -- Research on Bristol-Myers Squibb, AstraZeneca, Eli Lilly, and GlaxoSmithKline 9:16 a.m. May 1, 2014 - PR Newswire - PRF
Philanthropic Leaders Pledge $170 Million to Support Veterans and Military Families 11:11 a.m. April 30, 2014 - GlobeNewswire
Are Exosomes the Next PD-1 in Cancer Research? 10:01 a.m. April 30, 2014 - ACCESSWIRE
Kimberly-Clark Ranks Among Top 20 on '100 Best Corporate Citizens' Survey For Sixth Straight Year 4:35 p.m. April 29, 2014 - PR Newswire - PRF
North America Contrast Media Injectors Market Outlook to 2020 11:51 a.m. April 29, 2014 - PR Newswire - PRF
Metastatic Ovarian Cancer Global Clinical Trials Review, H1, 2014 3:10 p.m. April 28, 2014 - PR Newswire - PRF
Strategic Collaborations, Fresh Agreements, and Upcoming Conferences - Analyst Notes on Biogen, Bristol-Myers, AbbVie, Actavis and Bard 8:00 a.m. April 28, 2014 - PR Newswire - PRF
Schedule for Upcoming Earnings Releases -- Research on Nokia, Boston Scientific, Merck & Co., and Bristol-Myers Squibb 2:09 p.m. April 25, 2014 - PR Newswire - PRF
Bristol-Myers Squibb Ranks First on 2014 Best Corporate Citizens List 1:01 p.m. April 24, 2014 - BusinessWire - BZX
Allied Minds Names Peter Dolan and Jeff Rohr to Board of Directors 8:04 a.m. April 24, 2014 - BusinessWire - BZX
Quarterly Results, FDA Approvals, Intellectual Property Appeals, New Drug Applications, and Initiated Clinical Trials - Analyst Notes on Johnson & Johnson, Merck, Teva, Bristol-Myers Squibb and AbbVie 8:00 a.m. April 24, 2014 - PR Newswire - PRF
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2013 4:55 p.m. April 23, 2014 - PR Newswire - PRF
HIV Therapeutics in Major Developed Markets to 2019 - Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress Market Growth 1:05 p.m. April 23, 2014 - PR Newswire - PRF
North America Nuclear Imaging Equipment Market Outlook to 2020 12:48 p.m. April 23, 2014 - PR Newswire - PRF
North America Ultrasound Systems Market Outlook to 2020 12:36 p.m. April 23, 2014 - PR Newswire - PRF
Peregrine Pharmaceuticals Announces Initiation of an Investigator-Sponsored Trial Combining Its Immunotherapy Bavituximab and Ipilimumab (Yervoy(R)) in Advanced Melanoma 7:30 a.m. April 23, 2014 - Marketwire
Bristol-Myers Squibb and Samsung BioLogics Expand Manufacturing Agreement 7:00 p.m. April 22, 2014 - BusinessWire - BZX
Surveyed U.S. Physicians Expect Strong Uptake of Novel Oral Anticoagulants for the Treatment of VTE 11:30 a.m. April 17, 2014 - PR Newswire - PRF
FluoroPharma Appoints Dr. H. William Strauss, Internationally Recognized Expert in the Field of Cardiovascular Nuclear Medicine, to Chair the Scientific Advisory Board 7:27 a.m. April 14, 2014 - Marketwire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

IASLC Boosts Global Thoracic Cancer Collaboration

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Delhi Pushes Innovation Against Dryland Challenges

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Countries Eye New Investment Paths at CIFIT 2026

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

PathoSearch: A New Era in Pathology With Visual Search

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

ARTiSTORY's Strategic Advance in Cultural IP Licensing

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Silk Road Maritime Extends Its Global Reach in 2026

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Nocpix Unveils ACE 2 Thermal Riflescope Lineup

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...